Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis - PubMed (original) (raw)
Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis
M B Resnick et al. Cancer. 1995.
Abstract
Background: Patients with familial adenomatous polyposis develop periampullary adenomas at a high rate. However, little is known regarding the factors that control the growth, the natural history, or the malignant potential of these tumors.
Methods: In this study, the authors systematically evaluated the expression of the intestinal peptide growth factor, transforming growth factor-alpha (TGF-alpha), and its corresponding receptor, epidermal growth factor-receptor (EGF-R), in 49 periampullary adenomas and 6 periampullary carcinomas from 29 patients. Tumor proliferation rates were evaluated with the MIB-1 antibody.
Results: All periampullary adenomas and carcinomas (100%) had TGF-alpha expression, whereas 63% of adenomas and 67% of carcinomas expressed EGF-R. The extent of TGF-alpha expression was greater in carcinomas compared with adenomas and increased progressively in adenomas relative to the degree of dysplasia and villous architecture of these lesions. The extent of EGF-R expression correlated only with the degree of dysplasia in adenomas. With regard to proliferation kinetics, higher MIB-1 labeling indices were observed in adenomas that were larger, more severely dysplastic, and villous. Transforming growth factor-alpha, and to a lesser extent, EGF-R expression, correlated directly with the MIB-1 labeling indices.
Conclusions: These results support the adenoma-carcinoma sequence in the progression of malignancy in the duodenum in familial adenomatous polyposis, suggesting a possible involvement for TGF-alpha and EGF-R expression in this process.
Similar articles
- Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.
Wang J, Hollingshead J, El-Masry N, Horncastle D, Talbot I, Tomlinson I, Alison MR, El-Bahrawy M. Wang J, et al. J Gastrointest Cancer. 2012 Sep;43(3):444-55. doi: 10.1007/s12029-011-9330-9. J Gastrointest Cancer. 2012. PMID: 21989899 - Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway.
Estrella JS, Taggart MW, Rashid A, Abraham SC. Estrella JS, et al. Hum Pathol. 2014 Oct;45(10):2051-8. doi: 10.1016/j.humpath.2014.07.001. Epub 2014 Jul 24. Hum Pathol. 2014. PMID: 25149552 - Management of periampullary adenoma.
Norton ID, Gostout CJ. Norton ID, et al. Dig Dis. 1998 Sep-Oct;16(5):266-73. doi: 10.1159/000016876. Dig Dis. 1998. PMID: 9892786 Review. - Investigations on the significance of the adenoma-carcinoma sequence in the small bowel.
Sellner F. Sellner F. Cancer. 1990 Aug 15;66(4):702-15. doi: 10.1002/1097-0142(19900815)66:4<702::aid-cncr2820660419>3.0.co;2-z. Cancer. 1990. PMID: 2167140 Review.
Cited by
- Prevention and management of duodenal polyps in familial adenomatous polyposis.
Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM. Brosens LA, et al. Gut. 2005 Jul;54(7):1034-43. doi: 10.1136/gut.2004.053843. Gut. 2005. PMID: 15951555 Free PMC article. Review. No abstract available. - Management of advanced duodenal polyposis in familial adenomatous polyposis.
Soravia C, Berk T, Haber G, Cohen Z, Gallinger S. Soravia C, et al. J Gastrointest Surg. 1997 Sep-Oct;1(5):474-8. doi: 10.1016/s1091-255x(97)80136-9. J Gastrointest Surg. 1997. PMID: 9834381 Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous